vBloc® Therapy is a new, FDA-approved treatment that uses an electronic device, similar to a pacemaker, which controls hunger signals in your body and helps you eat less, lose weight and keep it off.
NYU Winthrop Hospital is the first in the tri-state area and one of the first in the country to offer this permanent weight loss solution that does not alter the anatomy, has almost no side effects and a minimal recovery time. A majority of people resume normal activity almost immediately. VBloc is reversible and the device can be recharged, adjusted or removed easily at any time.
NYU Winthrop Hospital also recently became the first in the country to enroll a patient in the ReNEW Study, a U.S. FDA post-approval study of the vBloc system that will evaluate long-term safety and effectiveness of vBloc for weight loss in obese patients in a real-world clinical setting.
Who Is a Candidate For vBloc® Therapy
To qualify for vBloc® Therapy, you should have:
- a BMI of 40 to 45
- a BMI of 35 to 39.9 with a health-related condition such as type 2 diabetes, sleep apnea or high blood pressure
- Participated in a supervised weight loss program within the last five years and been unable to maintain weight loss through diet and exercise
- Be at least 18 years of age
The vBloc Therapy Advantage
- Safe Technology
- Non-anatomy Altering
- Minimally Invasive
- No Side Effects
- Minimal Recovery Time
50% more weight loss than patients who did not receive vBloc Therapy.
28% average excess body weight loss in one year when vBloc was used for 12 hours per day.vBloc Therapy Results
vBloc Support & Resources
Together, vBloc Achieve and vBloc Therapy can help you reach your health and weight loss goals.vBloc Support & Resources
For additional information about vBloc Therapy or other weight loss programs and procedures at NYU Winthrop, please call 1-866-WINTHROP.